Segments - Global Hemodynamic Monitoring Market by Types (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.
The global hemodynamic monitoring market size is projected to expand at a CAGR of 3.85% during the forecast period. Growth of the market is attributed to rising monitoring system.
The process of measuring blood flow and pressure in the heart, veins, and arteries is referred to as hemodynamic monitoring. It allows the evaluation and optimization of hemodynamic parameters and oxygen delivery, which aids in the diagnosis and treatment of various cardiopulmonary conditions, as well as the improvement of outcomes in critically ill patients. Hemodynamic monitoring has progressed from basic tracking of cardiac output (CO) to advanced devices that provide data on a wide range of variables such as blood pressure, blood volume, and fluid balance. The number of people suffering from cardiac dysfunction has increased over time, resulting in hemodynamic instability and eventually organ failure. In line with this, the introduction of more innovative, uncalibrated, and non-invasive CO measurements obtained through non-invasive arterial pressure waveform analysis is boosting the market.
Furthermore, the hemodynamic monitoring segment is used more widely in the healthcare industry to improve patient outcomes and combat tissue hypoxia, shock, and multiorgan failure in critically ill patients. Manufacturers are working on the development of less invasive, non-invasive hemodynamic monitoring systems that will provide more precise results at a low cost. Other factors, such as rising healthcare spending by the public and private sectors, as well as technological advancements, are expected to drive the market during forecast period. According to the American heart association, approximately 69.0 percent of people experiencing cardiac arrest and 77.0 percent of people experiencing strokes for the first time have blood pressures greater than 140/90 mm Hg.
The report on the global hemodynamic monitoring market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Hemodynamic Monitoring Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2019–2020 |
Forecast Period |
2021–2028 |
Segmentation |
Types (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, GE Healthcare, and LiDCO Group |
Based on types, the global hemodynamic monitoring market is segregated into minimally invasive monitoring systems, invasive monitoring systems, and non-invasive monitoring systems. The minimally invasive monitoring systems segment is expected to hold a major market share and estimated to grow at a CAGR of 8.0% during forecast period. The minimally invasive systems aid in the continuous tracking of stroke volume and provide dynamic information on fluid responsiveness. Some systems assess volumetric preload variables, while others emphasize continuous measurement of central venous saturation with proprietary catheters. These minimally invasive system variables, along with cardiac output, provide improved hemodynamic monitoring.
In terms of regions, the global hemodynamic monitoring market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the hemodynamic monitoring market. The notable growth is in the US hemodynamic monitoring market, owing to the presence of major market players, technologically advanced hospitals, and an increasing number of critically ill patients being treated in the region's hospitals. The US hemodynamic monitoring market is expected to grow during the forecast period due to increased FDA approvals for monitoring devices and new product launches.
The global hemodynamic monitoring market is segmented on the basis of
The major players in the hemodynamic monitoring market include Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, GE Healthcare, and LiDCO Group.
Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.